Arcus Biosciences, Inc.
Clinical trials sponsored by Arcus Biosciences, Inc., explained in plain language.
-
New combo therapy shows promise in slowing advanced colon cancer
Disease control CompletedThis study tested a new drug called etrumadenant (AB928) combined with other treatments in 227 adults with metastatic colorectal cancer that has spread. The goal was to see if these combinations can slow cancer growth and are safe. Participants received different drug mixes, and …
Phase: PHASE1, PHASE2 • Sponsor: Arcus Biosciences, Inc. • Aim: Disease control
Last updated May 17, 2026 09:10 UTC
-
Healthy volunteers help uncover casdatifan drug interactions
Knowledge-focused CompletedThis study looked at how the drug casdatifan interacts with two other drugs (itraconazole and phenytoin) in 14 healthy adults. The goal was to measure how these drugs affect the levels of casdatifan in the blood. This information helps doctors understand how to adjust casdatifan …
Phase: PHASE1 • Sponsor: Arcus Biosciences, Inc. • Aim: Knowledge-focused
Last updated May 17, 2026 09:20 UTC
-
Healthy men help scientists track Drug's journey out of the body
Knowledge-focused CompletedThis study looked at how healthy adult men break down and get rid of a single dose of the experimental drug Quemliclustat. Eight participants received a radioactive-labeled version of the drug so researchers could measure it in blood, urine, and stool. The goal was to understand …
Phase: PHASE1 • Sponsor: Arcus Biosciences, Inc. • Aim: Knowledge-focused
Last updated May 11, 2026 20:41 UTC